ANIK Financial Facts

Selling, general & administrative: 2.4M
Provision for income taxes: 3.76M
See Full Income Statement

Deferred revenue: -4.39M
Total Liabilities and Stockholders' Equity: -290.59M
See Full Balance Sheet

Anika Therapeutics Inc. (ANIK) Earnings

  |   Expand Research on ANIK
Next EPS Date 5/23/14 *Est. EPS Growth Rate +41.9% *Last Qtr.
Average EPS % Beat Rate +56.1% Revenue Growth Rate -5.8% *Last Qtr.
Average % Move 1-Wk after EPS +12.5% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
5/4/11 Q111 $0.02N/A N/A $11.7MN/A N/A +377.9% Details
3/9/11 Q410 $0.10N/A N/A $14.2MN/A N/A +344.9% Details
8/4/11 Q211 $0.17N/A N/A $16.1M$13.7M N/A +557.7% Details
2/29/12 Q411 $0.21N/A N/A $18.4M$14.7M N/A 0% Details
11/2/11 Q311 $0.22$0.11 +$0.11$18.5M$15.1M N/A +551.2% Details
10/30/13 Q313 $0.33$0.14 +$0.19$17.8M$16.96M N/A +47.5% Details
10/30/12 Q312 $0.11$0.17 -$0.06$14.8M$16.83M N/A +223.7% Details
5/3/12 Q112 $0.14$0.17 -$0.03$14.4M$18.2M N/A +136.6% Details